Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
From www.bloodjournal.org by guest on June 16, 2017. For personal use only. Concentration of Fetal Red Blood Cells From a Mixture ofMaternal and Fetal Blood by Anti-i Serum-An Aid to Prenatal Diagnosis of Hemoglobinopathies Yuet By Fetal red from Wai blood mixtures differential This David cells of with be useful Gabriel concentrated and fetal agglutination will G. Nathan. were of maternal method nosis Kan. cells by serum. anti-i for prenatal diag- when blood hemoglobinopathies to detect sickle trait a reliable method developed, it has been that Marie from by maternal cells. The method is except in very rare cases in which the maternal nated the C. Crookston obtained red fetus cells is are synthesis in fetal of sickle cell anemia1-2; placental heavily strongly con- aggluti- by anti-i. in aborted midterm of sampling fetal suggested and taminated practical, EASUREMENT OF HEMOGLOBIN proposed for the prenatal diagnosis been used Although Cividalli, blood has this method fetuses.2-3 blood in utero blood may has not be adequate been has yet been for studies of amino acid incorporation because the rate of globin synthesis in fetal cells is much higher than that in adult cells.2 However, extensive contamination by maternal blood remains a potentially significant problem. To overcome this difficulty, we have used a method for separating fetal cells from a mixture of fetal and adult cells by agglutinating them with the antibody, MATERIALS Fetal blood Blood was thalassemia. From was obtained obtained from the Division the Department Service and the the california, San ronto. Canada. Hartford Yuet Calif 94/22 adult of Medical Francisco General Professor from the pital. Jerusalem, recipient USPHS; M.D.: of Pediatrics, Fellow, Children’s of an International on temporary Israel. leave from C. Marie and and the Departjnent Crookston, and Chief, Division Harvard Hospital. San School, Postdoctoral Research the Department B.Sc.: Assistant Francisco, Calif University General Boston, and Hospital Mass. Harvard Fellowship Professor of To- Cividalli, Medical Hadassah San Medical Gabriel (1 F05 of Associate of California. Children’s of Pediatrics, 94110, of Toronto, Hospital; University Center Medical 16666 and by grants from of Dimes, the John A. of Hematology. Medical cell the Hematology Medicine, University Medicine, sickle Hospitat 02115, Laboratory July 29, 1973. A M-05581, AM Foundation-March Medical Hospital with Children’s Mass. of Pathology, Laboratory at hysterotomy. a patient Boston, Council of Canada. Service, San Francisco and removed from Medicine. School. Pathology Research Hematology fetuses donors, Department Clinical Pathology G. Nathan, Research Mass.; of Toronto. and Clinical David Associate Special Boston, 15-20-wk-old March 4, 1973; re vised July 16, l973, accepted by USPHS Grants A M-05322. A M-15913. Foundation of Boston, Inc., the National Calif Center; the San and METHODS of normal Harvard Laboratories, Francisco. of Medicine Francisco, School, TW-1 781-02) University Hos- Pathology. University Canada. 1974 by Grune Blood, of Medicine cord other Hematology of AND umbilical mother, Foundation, and the Medical Wai Kan, M. B., B.S.: Chief, Professor M.D.: the of Pediatrics. Clinical Departments Submitted Supported the Medical the of Center, and from anti-i.4 & Stratton, Vol. 43, No. 3 (March), Inc. 1974 411 From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 412 KAN Table 1. Recovery and Concentration of Artificial Total CPM x 1O Before Agglutination Per Cent Fetal 14 Cells in Initial Mixture H Maternal (p) (a) Fetal Blood in Fetal (c) Percent Per Cent Recovery C Maternal Fetal (in) (d) 165.1 Agglutinated Cells (f) (q) 76.9 100% 3.0 76.2 7.3 73.0 90.9% 20 100.9 64.4 2.7 44.1 2.7 68.5 86.4% 10 187.6 55.3 1.5 21.7 0.8 39.2 84.6% 387.3 51.3 1.7 13.1 0.5 25.6 75.0% 41.0 5 c xlOO a “Agglutinated” m= cell cells sample packed red cells patible plasma 2 mg glucose. fetal and cell were then suspension Tables I and was pipetted four number times with the buffer, at 37’C, of 3H leucine (50 experiments, washed in saline. the 3H and Table 2. cell were expressed Reproducibility “C leucine to the labels were reversed.) were was measured vial containing (0.9% then adult cells; before in the Cells was preparing Adult Cells Agglutination From Method mixture before for Fetal Cells In Agglutinated Cells - S 1 Adult (AA) 2 Adult (AA) 3 4 5 10 52.3 71.1 5 56.9 76.4 Adult and Methods. 50.4 10 (S-ThaI) See Materials 31.2 (AA) (AA) 5 5 10 Maternal Maternal in was cooled counting the Mixtures In Initial Mixture type) a 20% as follows: a IO-pI aliquot of each sample 0.5 ml water. After the addition of 0.5 ml Percent (Hemoglobin to was shown Source of Expenment and added incubation proportions was incubated at 37’C for 2 hr. The England Nuclear Corp.) was added as counts per minute of 3H and “C. Fetal of com- leucine), pCi/mmole) NaCI) made milliliter (without (300 added One-half 0.5 ml serologically of 19 I-amino-acids saline and Methods). buffer. ml buffer, was mixtures of Differential Concentrating 0.5 of “C with normal 30% hydrogen peroxide, the tightly capped vial to room temperature and 10 ml Aquasol (New The results of each 3 pCi (see Materials phosphate containing Ci/mmole) four times Fetal-adult free cells Krebs-Ringer 20 pmoles preincubation 2. The uptake of radioactive label into a liquid scintillation counting 3H and “C activity. of residual in I ml of a mixture against for 2 hr. (In some samples a small washed 30 pCi -xlOO pf+(100-p)m included 10 mm 0 p1 q= resuspended dialysed After cells, continued d -xlOO b was was 0 0 1= - Each 104.3 80.0 0 (v/v) Agglutination Cells Cells 14 H Maternal (b) by Differential AL. 1O 214.5 50 The x 3 C Fetal 100 the Total CPM Agglutinated in Cells of Fetal of Fetal and Maternal Mixtures ET 5 77.0 10 87.6 5 71.5 10 85.0 From www.bloodjournal.org by guest on June 16, 2017. For personal use only. CONCENTRATION OF For differential volumes lightly to dislodge and sediment of diluted moval ml distilled fetal 5 mm, and and chains differential relative as previously unlabeled 1 : 10; the cell In order solution for 30 mm After were the described.2 mixtures The cells were for 3H and preparation were agglutinated whether cells from and mothers temperature the cells, recovery cells, by radioactivity to 3 ml of adult was were and after cellulose determined. cells and calculated. fetal cells, before carboxymethyl adult re0.5 As a con- in the proportions as before. heterozygous were agglutinated by anti-i under the conditions described were tested with serum Den. The red cells of normal adult parallel. centnifuallowed agglutinated The and 3H leucine-labeled analyzed The were 20 tapped tapped twice more. After free cells) were lysed with activity. adult separated with 2 mm, (2 1 ‘ C). To the and residual “C mixed agglutinates of agglutinated of chain with was g for at 300 by aspiration. centrifuged cells (and ratios mixed preparation tapping, was counted cell centrifuged at room last removed in the final red were from 3H and “C leucine-labeled procedure. The chains were fetal to ascertain was proportions trol tubes the cell-serum mixture as possible, the agglutinated were prepared agglutination experiment, incubated cells of each The repeated. the suspended chromatography I : 1 and was 413 I volume (Den). and tubes CELLS anti-i, of anti-i 10 pl of this their Globin the of the water; cells, with dilution anti-i was added; many free cells ofas BLOOD the agglutinates, tapping for RED agglutination of a I-in-SO gation FETAL for above, -thalassemia or hemoglobin the red cells of 62 selected subjects and newborn infants S patients were tested in RESULTS The cells separated procedure with anti-i q in Table from the artificial were predominantly I, it can (15-fold) when blood. relative When the enrichment increased, be seen the initial that mixtures by the differential fetal cells. By comparing the degree mixture of enrichment contained the of fetal smallest of fetal cells cells proportion initial mixture contained a larger proportion was less but the actual recovery of fetal as did the proportion agglutination columns p and in the separated cells was greatest (5%) of fetal of fetal cells, cells (column (column the f) q). Table contained 2 shows the results of only low concentrations glutination periment When with anti-i, there was a marked enrichment of fetal cells in each ex(including one in which the adult donor had hemoglobin S-thalassemia). the globin chains of fetal cells were analyzed before and after aggluti- nation with Table 3). anti-i, no change in the A disproportionate elevation maternal of the blood agglutinated found in the loss ratio of beta and unlabeled cells alpha- were and further experiments in which the cell mixtures of fetal cells (5%-lO%). After differential ag- ratio of beta plus gamma cord blood similarly beta-chain to gamma of alpha-chain tests, the cells Table of all 50 newborn 3. Ratios analyzed, region, and normal of Radioactivity barely detectable no gamma-chain normal with infants Before agglutination agglutination with with anti-i anti-i detected shown of Globin Chains radioactivity radioactivity subjects reacted hemoglobinopathies. reacted 0 After was was (see by the to alpha. When a mixture of 3H-labeled was subjected to agglutination, and the detected. (Data not shown.) As shown in Table 4, the cells of two of 70 adult with anti-i, as did the cells of 14 of the 62 patients these chains radioactivity in Fetal very strongly. Blood 0+-y V a 0.07 0.89 0.07 1.10 was was weakly In From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 414 KAN Table 4. The Reactio n With Anti-i of Re d Cells From Pat ients Adult Tested Type patients With Anti-i Weak Strong 62 SA 16 3 0 SC 4 1 3 0 SS 2 1 1 0 CA 3 3 0 0 CC 1 1 0 0 6 0 $thal 27 3 Normal adult Normal newborn Agglutination 13 33 trait ethaltrait . Negative AL. Hemoglobinopathies Reaction Number Hemoglobin With ET 2 70 50 at 20#{176} C by serum Den. diluted 1 0 68 2 0 0 0 50 1 : 50. DISCUSSION These results show that differential of concentrating fetal red cells example, an initial concentration agglutination in mixtures of 5% by anti-i is an effective containing fetal and fetal cells was enriched differential agglutination. Such concentrations of fetal cells tection of beta-chain synthesis in fetal cells against a background The moderate loss of fetal cells during the procedure is well enrichment. Kleihauer-Betke stains5 of fetal blood show that the means maternal cells. six- to 16-fold permit accurate of maternal compensated distribution For by decells. by the of hemo- globin A in the developing fetus is clonal.#{176} The data in Table 3 in the present paper indicate that the treatment with anti-i did not cause a selective loss of fetal cells containing hemoglobin A, since the beta to gamma globin chain radioactivity ratios remained unaltered by this treatment. We conclude that the i antigen is present on fetal cells in which the switch from gamma-chain to beta-chain production has occurred. The partial loss of alpha-chain activity is not explained at present, but this loss is not important when the object is to detect beta-chain abnormalities. Increased maternal synthesis of hemoglobin F during the first trimester of pregnancy has been described.7 In the present study, the gamma chains of hemoglobin derived by chromatography from the agglutinated cells in a mixture of 3H-labeled maternal cells and nonlabeled fetal cells were not detectably radioactive. Thus, since maternal cells containing fetal hemoglobin were not agglutinated by this particular example of anti-i, they did not interfere with the detection of hemoglobin A synthesis in the fetal cells. hematologic disorders, particularly are strongly agglutinated by anti-i.8 The results small increase in i antigen is occasionally found or $-Thal gene, but that the agglutinability of less than that of fetal cells. Thus the differential agglutination, method of plied to samples obtained by placental aspirate, In some (1) Estimate (2) Incubate the percentage of fetal cells cells with radioactive amino thalassemia major, adult red cells shown in Table 4 suggest that a in patients heterozygous for the S these cells by anti-i is consistently concentrating in the following by the Kleihauer-Betke acid. fetal cells can be apmanner: technique.5 From www.bloodjournal.org by guest on June 16, 2017. For personal use only. CONCENTRATION (3) OF FETAL samples When RED are BLOOD CELLS found 415 to have significant maternal cell contamination, separate fetal cells by differential agglutination with anti-i. (4) Test a sample of the mother’s blood with anti-i, in parallel with the placental sample. If the maternal i antigen is greatly increased, it may be difficult to separate fetal cells using anti-i. In some such cases, a difference in the ABO groups of mother and fetus glutination can of fetal be exploited by using anti-A or anti-B for the differential ag- cells. ACKNOWLEDGMENT We are indebted Tilley to Dr. D.H. for technical Cowan for anti-i serum, and to Miss Andr#{233}e Dozy and Mrs. Christine assistance. REFERENCES I. Hollenberg MD, Kaback MM, 5. Kazazian HH: Kleihauer Adult hemoglobin synthesis by reticulocytes from human fetus at mid-trimester. Science 174:698, 1971 2. Kan YW, Dozy AM, Alter BP, Frigoletto onstration FD, the in Nathan the DG: human diagnosis 287:1, 3. Sickle fetus: of sickle Potential cell for anemia. cell gene intrauterine N EngI J HH, cell 7:200, Kaback MM, hemoglobin fetus. Marsh eines 35:637, 6. Pediatr WL: 1961 Anti-i: in Res an 6:358, a cold in human Nersesian red aborted Betke H, Blutausstrichs. K: DemErythWochenschr HAmoglobin in den KIm 1957 Zilliacus blood 11:389, Braun fetalen H, of Ottelin human AM: Haemoglobins embryos. Biol in Neonate 1967 Med 1972 the Ii relationship matol of the sickle rocyten 7. Kazazian trimester 4. Detection E, von WS: mid- antibody defining cells. Br J Hae- ME, synthesis of Haematol 2 1:355, 8. 1972 Pembrey of red Giblett cells major and Nature (Lond) Weatherall hemoglobin ER, Di: F in Maternal pregnancy. Br 1971 Crookston by anti-i other 201:1138, MC: in patients haematological 1964 Agglutinability with thalassemia disorders. J From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 1974 43: 411-415 Concentration of Fetal Red Blood Cells From a Mixture of Maternal and Fetal Blood by Anti-i Serum−−An Aid to Prenatal Diagnosis of Hemoglobinopathies Yuet Wai Kan, David G. Nathan, Gabriel Cividalli and Marie C. Crookston Updated information and services can be found at: http://www.bloodjournal.org/content/43/3/411.full.html Articles on similar topics can be found in the following Blood collections Information about reproducing this article in parts or in its entirety may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests Information about ordering reprints may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#reprints Information about subscriptions and ASH membership may be found online at: http://www.bloodjournal.org/site/subscriptions/index.xhtml Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036. Copyright 2011 by The American Society of Hematology; all rights reserved.